EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Open Access · CC BY-NC 4.0

A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?

Basak Tas iD, Nicola J Kalk iD, Edward Chesney, Rob van der Waal, Alastair Boyd, James Bell, Mike Kelleher, John Moxham, Will Lawn iD, Caroline J Jolley, John Strang iD

Addiction · 2025

DOI: 10.1111/add.70005 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Addiction, 2025. Verfasst von Basak Tas und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Addictions Department, King's College London, London, UK. Hauptthemen laut MEDLINE: Heroin, Heroin Dependence, Respiratory Insufficiency, Opiate Overdose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIHR Maudsley Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aim Globally, more than 100 000 people die annually from opioid overdose. Although strongly implicated in heroin overdose deaths, acute opioid‐induced respiratory depression is poorly understood, and few laboratory studies have been completed in human subjects. It is an area of undone science. Using a human laboratory overdose model, our research question was: what is the strength of the association between increasing dose of diamorphine and degree of respiratory depression in people prescribed injectable diamorphine for heroin use disorder?

Design

Single‐blind, Phase IV, non‐randomised, dose‐escalation clinical trial.

Setting

King's Clinical Research Facility, London, UK.

Participants

Four participants prescribed injectable diamorphine as treatment for heroin use disorder [all male, median (range) age 63 (59–72)].

Interventions

The following dosing schedule was implemented (as a % of participant's usual prescribed diamorphine dose): visit 1–100%; visit 2–110%; visit 3–120%; visit 4–100%. Usual dose: 97.5 mg (30 mg–200 mg).

Measurements

Physiological measures included: pulse oximetry (SpO 2 %), end‐tidal CO 2 (ETCO 2 %), transcutaneous CO 2 , respiratory rate and parasternal electromyography to measure neural respiratory drive index (NRDI). Recordings were made continuously from 3 mins pre‐dose to 60 mins post‐dose.

Findings

Respiratory measures from baseline to post‐dose across all dose sessions had ranges of: 89.7%–99.5% SpO 2 %; 4.8%–7.7% ETCO 2 %; 5.2–13.4 breaths/minute respiratory rate; 51.2 min −1 –165.9 min −1 NRDI across all participants. All diamorphine doses caused some reduction in respiratory function. There was no clear difference between diamorphine dose and the degree of respiratory depression, based on descriptive analyses.

Conclusions

A dose‐escalation clinical trial of people prescribed injectable diamorphine for heroin addiction found that the degree of respiratory depression caused by diamorphine does not appear to be dose dependent; however, the changes seen at diamorphine doses to which participants were accustomed suggest that participants had only partial tolerance to the respiratory depressant effect of diamorphine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeroinHeroin DependenceRespiratory InsufficiencyOpiate OverdoseNarcoticsHumansMaleMiddle AgedSingle-Blind MethodAgedDose-Response Relationship, DrugDrug Overdose

Stichwörter der Autor:innen

dose‐escalationdrug‐related deathsexperimental researchheroinopioidsoverdose

Substanzen

HeroinNarcotics

Autor:innen und Institutionen

  • National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), Addictions Department, King's College London, London, UK.
  • South London and Maudsley NHS Foundation Trust, London, UK.
  • Department of Respiratory Medicine, King's College Hospital NHS Foundation Trust, King's Health Partners, London, UK.
  • Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

ORCID-Profile: Basak Tas, Nicola J Kalk, Will Lawn, John Strang

Förderung

  • NIHR Maudsley Biomedical Research Centre

Zitieren

APA

Tas, B., Kalk, N. J., Chesney, E., van der Waal, R., Boyd, A., Bell, J., Kelleher, M., Moxham, J., Lawn, W., Jolley, C. J., & Strang, J. (2025). A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?. Addiction. https://doi.org/10.1111/add.70005

Vancouver

Tas B, Kalk NJ, Chesney E, van der Waal R, Boyd A, Bell J, et al. A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?. Addiction. 2025. doi:10.1111/add.70005

BibTeX
@article{Tas2025,
  author = {Tas, Basak and Kalk, Nicola J and Chesney, Edward and van der Waal, Rob and Boyd, Alastair and Bell, James and Kelleher, Mike and Moxham, John and Lawn, Will and Jolley, Caroline J and Strang, John},
  title = {A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70005}
}
Kostenlos starten →